Rapid SARS-CoV-2 IgG Antibody Testing in high risk healthcare workers and candidacy for convalescent plasma therapy/prophylaxis
The purpose of the research is to determine if a certain marker in the blood (IgG to SARS-CoV-2) can tell if persons have been exposed to and now recovered from SARS-CoV-2.
Participants will be given a kit and a link to fill out a short questionnaire to determine demographics, potential exposure risk, and the presence of recent clinical symptoms consistent with SARS-COV-2 infection. Contact information will also be collected.
A kit and instructions will be given to participants to perform a single blood test at home. Blood will be obtained via a finger prick. Procedure takes 2-3 minutes with results available within 10 minutes. If the test is negative: no further intervention, continue prevention as usual, can be retested with finger prick test in 21 days for a maximum of three times. If the test is positive: blood draw for serologic testing of IgG and validate the rapid test, and a nasal swab at an IU Health testing site to confirm by PCR (polymerase chain reaction) that the infection is not active anymore.
- IRB Number: 2003973826
- Research Study Identifier: 2003973826
- Principal Investigator: Courtney Rowan, MD
Recruitment StatusEnrolling By Invitation
If you need help finding a study or have any questions, please contact us at email@example.com or by phone at (888) 264-0005.